Bio-Rad Laboratories, Inc.BIONYSE
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank57
5Y CAGR-9.4%
Year-over-Year Change
Year-over-year operating cash flow growth rate
5Y CAGR
-9.4%/yr
Long-term compound
Percentile
P57
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
2 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | 16.92% |
| 2024 | 21.41% |
| 2023 | 92.83% |
| 2022 | -70.95% |
| 2021 | 14.44% |
| 2020 | 27.75% |
| 2019 | 60.39% |
| 2018 | 174.15% |
| 2017 | -51.80% |
| 2016 | 16.03% |